Is the current model fit for purpose?
These are symptoms of a decline of the pre-digital era model of medicinal product development. Our pharmaceutical industry members are those who are committed to moderninsing their product development to create safer and more effective medicinal products.
Modernisation of the pharmaceutical industry requires a coresponding moderninsation of the way in which medicinal products are brought on to the market and the design of clinical trials. The Avicenna Alliance is working to promote modelling and simulation as a means of addressing the high cost of research and the uptake of in silico methods.